?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
March 18, 2021
signalgroup
Biosimilars Forum Statement on The Confirmation of Xavier Becerra As U.S. Secretary of Health And Human Services
News
March 18, 2021
signalgroup
New Economic Report Demonstrates How Biosimilar Competition Lowers Prices
News
November 30, 2020
signalgroup
Viatris Inc. Joins Biosimilars Forum
News
November 23, 2020
signalgroup
The Biosimilars Forum Announces Meaghan Rose Smith as Executive Director
News
November 19, 2020
signalgroup
Biosimilars Forum Statement at FDA’s BsUFA III Kick-off Meeting
News
October 6, 2020
signalgroup
Biosimilars Could Generate $100 Billion in Savings Over Next Five Years, New Report Finds
News
September 21, 2020
signalgroup
U.S. Taxpayers and the Health Care System At-Large Have Lost out on Nearly $20 Billion in Savings Since 2018
News
September 10, 2020
signalgroup
The Biosimilars Forum Filed Comment on FDA’s Notice Detailing the Impact of Disclosure Statements in Biosimilar Promotional Materials
News
July 31, 2020
signalgroup
ICYMI: Experts Detail How Shared Savings Model for Biosimilars Could Provide Savings for Seniors, Patients and Medicare
News
July 31, 2020
signalgroup
MedPac: Top 10 Most Expensive Medicare Part B Drugs are Originator Biologics
Prev page
07
08
09
10
11
Next page